1. Home
  2. ARES vs ALC Comparison

ARES vs ALC Comparison

Compare ARES & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARES
  • ALC
  • Stock Information
  • Founded
  • ARES 1997
  • ALC 1945
  • Country
  • ARES United States
  • ALC Switzerland
  • Employees
  • ARES N/A
  • ALC N/A
  • Industry
  • ARES Investment Managers
  • ALC Ophthalmic Goods
  • Sector
  • ARES Finance
  • ALC Health Care
  • Exchange
  • ARES Nasdaq
  • ALC Nasdaq
  • Market Cap
  • ARES 37.1B
  • ALC 43.2B
  • IPO Year
  • ARES 2014
  • ALC N/A
  • Fundamental
  • Price
  • ARES $182.66
  • ALC $87.86
  • Analyst Decision
  • ARES Buy
  • ALC Buy
  • Analyst Count
  • ARES 13
  • ALC 10
  • Target Price
  • ARES $180.50
  • ALC $106.88
  • AVG Volume (30 Days)
  • ARES 1.3M
  • ALC 1.5M
  • Earning Date
  • ARES 08-01-2025
  • ALC 08-19-2025
  • Dividend Yield
  • ARES 2.45%
  • ALC 0.25%
  • EPS Growth
  • ARES N/A
  • ALC 6.66
  • EPS
  • ARES 1.76
  • ALC 2.25
  • Revenue
  • ARES $4,266,223,000.00
  • ALC $9,925,000,000.00
  • Revenue This Year
  • ARES $17.20
  • ALC $6.75
  • Revenue Next Year
  • ARES $24.20
  • ALC $7.60
  • P/E Ratio
  • ARES $104.01
  • ALC $39.13
  • Revenue Growth
  • ARES 21.00
  • ALC 3.80
  • 52 Week Low
  • ARES $110.63
  • ALC $80.48
  • 52 Week High
  • ARES $200.49
  • ALC $101.10
  • Technical
  • Relative Strength Index (RSI)
  • ARES 55.52
  • ALC 47.15
  • Support Level
  • ARES $175.40
  • ALC $89.94
  • Resistance Level
  • ARES $190.08
  • ALC $91.61
  • Average True Range (ATR)
  • ARES 4.64
  • ALC 1.50
  • MACD
  • ARES -0.05
  • ALC -0.08
  • Stochastic Oscillator
  • ARES 54.70
  • ALC 33.29

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: